Published online Feb 16, 2025. doi: 10.4253/wjge.v17.i2.100556
Revised: December 31, 2024
Accepted: January 21, 2025
Published online: February 16, 2025
Processing time: 177 Days and 6.5 Hours
In this letter we comment on the article by Zhang et al published in the recent issue of the World Journal of Gastrointestinal Endoscopy 2024. We focus specifically on the management of gastric varices (GV), which is a significant consequence of portal hypertension, is currently advised to include beta-blocker therapy for primary prophylaxis and transjugular intrahepatic portosystemic shunt for secondary prophylaxis or active bleeding. Although it has been studied, direct endoscopic injection of cyanoacrylate glue has limitations, such as the inability to fully characterize GV endoscopically and the potential for distant glue embolism. In order to achieve this, endoscopic ultrasound has been used to support GV characterization, real-time therapy imaging, and Doppler obliteration verification.
Core Tip: The primary treatment for isolated gastric varices (IGVs), which have the potential to be harmful, is endoscopic. Treatment guided by endoscopic ultrasonography (EUS) is more accurate than traditional endoscopic therapy. In this situation, EUS-guided coil embolization in combination with cyanoacrylate injection proved to be an effective treatment method for an IGV entangled with an artery. This was a successful treatment for an IGV that was entangled in an artery.